These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36250610)

  • 1. Erythrocyte membrane camouflaged siRNA/chemodrug nanoassemblies for cancer combination therapy.
    Xu J; Chen T; Sun T; Yu C; Yan D; Zhu L
    Biomater Sci; 2022 Nov; 10(22):6601-6613. PubMed ID: 36250610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-cell-membrane-camouflaged supramolecular self-assembly of antisense oligonucleotide and chemodrug for targeted combination therapy.
    Chen T; Xu J; Zhu L; Yan D
    Nanoscale; 2023 Jan; 15(4):1914-1924. PubMed ID: 36617999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid Membrane Camouflaged Chemodrug-Gene Nanoparticles for Enhanced Combination Therapy of Ovarian Cancer.
    Chen T; Wang Y; Zhu L; Wu J; Lin J; Huang W; Yan D
    ACS Appl Mater Interfaces; 2023 Dec; 15(50):58067-58078. PubMed ID: 38056905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrostatic Attractive Self-Delivery of siRNA and Light-Induced Self-Escape for Synergistic Gene Therapy.
    Yang Y; Ning H; Xia T; Du J; Sun W; Fan J; Peng X
    Adv Mater; 2023 Jul; 35(30):e2301409. PubMed ID: 37084041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
    Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte Membrane-Wrapped pH Sensitive Polymeric Nanoparticles for Non-Small Cell Lung Cancer Therapy.
    Gao L; Wang H; Nan L; Peng T; Sun L; Zhou J; Xiao Y; Wang J; Sun J; Lu W; Zhang L; Yan Z; Yu L; Wang Y
    Bioconjug Chem; 2017 Oct; 28(10):2591-2598. PubMed ID: 28872851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A RBC membrane-camouflaged biomimetic nanoplatform for enhanced chemo-photothermal therapy of cervical cancer.
    Luo L; Zeng F; Xie J; Fan J; Xiao S; Wang Z; Xie H; Liu B
    J Mater Chem B; 2020 May; 8(18):4080-4092. PubMed ID: 32239064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
    Gandhi NS; Tekade RK; Chougule MB
    J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylated cationic nanoassemblies based on triblock copolymers to combine siRNA therapeutics with anticancer drugs.
    Conte C; Dal Poggetto G; Schiano Di Cola V; Russo A; Ungaro F; Russo G; Laurienzo P; Quaglia F
    Biomater Sci; 2021 Sep; 9(18):6251-6265. PubMed ID: 34369494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A self-amplified ROS-responsive chemodrug-inhibitor conjugate for multi-drug resistance tumor therapy.
    Sun T; Xu J; Chen T; Tu C; Zhu L; Yan D
    Biomater Sci; 2022 Feb; 10(4):997-1007. PubMed ID: 35044379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic siRNA delivery to tumors by cell-penetrating α-helical polypeptide-based metastable nanoparticles.
    Liu Y; Song Z; Zheng N; Nagasaka K; Yin L; Cheng J
    Nanoscale; 2018 Aug; 10(32):15339-15349. PubMed ID: 30070662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-responsive DNA nanomicelles for chemo-gene synergetic therapy of anaplastic large cell lymphoma.
    Li Y; Yue S; Cao J; Zhu C; Wang Y; Hai X; Song W; Bi S
    Theranostics; 2020; 10(18):8250-8263. PubMed ID: 32724469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance.
    Yhee JY; Song S; Lee SJ; Park SG; Kim KS; Kim MG; Son S; Koo H; Kwon IC; Jeong JH; Jeong SY; Kim SH; Kim K
    J Control Release; 2015 Jan; 198():1-9. PubMed ID: 25481438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visible light-switched cytosol release of siRNA by amphiphilic fullerene derivative to enhance RNAi efficacy in vitro and in vivo.
    Wang J; Xie L; Wang T; Wu F; Meng J; Liu J; Xu H
    Acta Biomater; 2017 Sep; 59():158-169. PubMed ID: 28511875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments.
    Van de Vyver T; Muntean C; Efimova I; Krysko DV; De Backer L; De Smedt SC; Raemdonck K
    J Control Release; 2023 Dec; 364():142-158. PubMed ID: 37816483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
    Chen G; Wang Y; Xie R; Gong S
    J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming Multidrug Resistance by Codelivery of MDR1-Targeting siRNA and Doxorubicin Using EphA10-Mediated pH-Sensitive Lipoplexes: In Vitro and In Vivo Evaluation.
    Zhang J; Du Z; Pan S; Shi M; Li J; Yang C; Hu H; Qiao M; Chen D; Zhao X
    ACS Appl Mater Interfaces; 2018 Jun; 10(25):21590-21600. PubMed ID: 29798663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.